These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9627742)

  • 1. Association between regional brain volumes and clozapine response in schizophrenia.
    Lauriello J; Mathalon DH; Rosenbloom M; Sullivan EV; Faustman WO; Ringo DL; Lim KO; Pfefferbaum A
    Biol Psychiatry; 1998 Jun; 43(12):879-86. PubMed ID: 9627742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.
    Ahmed M; Cannon DM; Scanlon C; Holleran L; Schmidt H; McFarland J; Langan C; McCarthy P; Barker GJ; Hallahan B; McDonald C
    Neuropsychopharmacology; 2015 Sep; 40(10):2409-17. PubMed ID: 25829144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients.
    Molina V; Tamayo P; Montes C; De Luxán A; Martin C; Rivas N; Sancho C; Domínguez-Gil A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):948-54. PubMed ID: 18262704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study.
    Potvin S; Tikàsz A; Lungu O; Dumais A; Stip E; Mendrek A
    Schizophr Res; 2015 Oct; 168(1-2):377-80. PubMed ID: 26255082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia.
    Friedman L; Knutson L; Shurell M; Meltzer HY
    Biol Psychiatry; 1991 May; 29(9):865-77. PubMed ID: 2049485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cortical anatomy and clozapine response in refractory schizophrenia.
    Honer WG; Smith GN; Lapointe JS; MacEwan GW; Kopala L; Altman S
    Neuropsychopharmacology; 1995 Aug; 13(1):85-7. PubMed ID: 8526974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
    Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.
    Molina V; Reig S; Sarramea F; Sanz J; Francisco Artaloytia J; Luque R; Aragüés M; Pascau J; Benito C; Palomo T; Desco M
    Psychiatry Res; 2003 Nov; 124(3):153-61. PubMed ID: 14623067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.
    Smith RC; Baumgartner R; Ravichandran GK; Largen J; Calderon M; Burd A; Mauldin M
    Acta Psychiatr Scand; 1987 Jan; 75(1):11-9. PubMed ID: 2883814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.